Results 121 to 130 of about 112,374 (313)

Prognostic value of N‐terminal pro C‐type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction [PDF]

open access: bronze, 2014
Dirk J. Lok   +8 more
openalex   +1 more source

Management of Chronic Heart Failure with Reduced Ejection Fraction

open access: yesThe Journal of the American Board of Family Medicine
Heart failure with reduced ejection fraction (HFrEF) is a commonly seen clinical entity in the family physician's practice. This clinical review focuses on the pharmacologic management of chronic HFrEF. Special attention is paid to the classification of heart failure and the newest recommendations from the American Heart Association concerning the use ...
Brandon, Williamson, Carl, Tong
openaire   +2 more sources

Breaking the Barrier: Unraveling the No‐Reflow Phenomenon in Cardiovascular Medicine

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The no‐reflow phenomenon is a stubborn and often devastating complication in cardiovascular medicine, where blood flow is restored to an artery, yet the microvasculature remains unresponsive. First identified in 1967, this phenomenon has haunted clinicians and researchers alike, particularly in the context of acute myocardial infarction (AMI).
Stephanie Howes   +9 more
wiley   +1 more source

Minimum Lumen Area Indexed to Left Ventricular Mass to Identify Functionally Significant Left Main Coronary Stenoses

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background and Aim Diagnosing significant left main coronary artery (LMCA) stenoses based on anatomical criteria remains challenging. The ARMYDA FINISH multicenter study evaluated whether indexing intravascular ultrasound (IVUS)‐derived minimum lumen area (MLA) provides greater diagnostic accuracy than unindexed MLA for detecting ...
Giuseppe Patti   +12 more
wiley   +1 more source

The Predictive Value of Quantitative Flow Ratio and Its Derived Angiographic Microvascular Resistance for Restenosis Following Drug‐Coated Balloon Angioplasty

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Initially, drug‐coated balloon (DCB) angioplasty was primarily employed for in‐stent restenosis (ISR) treatment. Over time, its indications have broadened to include de novo small‐vessel lesions and bifurcation lesions. However, there is a lack of effective strategies to reduce restenosis rates post‐DCB angioplasty.
Chenhang Wang, Li Chen, Xiaoyong Xu
wiley   +1 more source

Re‐Exploration of Flow Rate in Low‐Flow, Low‐Gradient Aortic Stenosis

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transaortic flow rate (TFR, mL/s) is an emerging hemodynamic index in aortic stenosis (AS), offering insights beyond stroke volume index (SVi). We evaluated the hemodynamic determinants and prognostic significance of TFR at rest and peak dobutamine stress in patients with suspected low‐flow, low‐gradient (LF‐LG) AS and reduced left ...
Sara Hungerford   +5 more
wiley   +1 more source

Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction [PDF]

open access: bronze, 2015
Lee Lee Wong   +23 more
openalex   +1 more source

Impact of Femoropopliteal Drug‐Coated Balloon Use on Clinical Outcomes in Patients With Chronic Limb‐Threatening Ischemia

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions have demonstrated superiority over standard percutaneous transluminal angioplasty (PTA) in maintaining vessel patency. However, data on whether the good durability of DCBs translates into improved wound outcome in chronic limb‐threatening ischemia (CLTI) patients are ...
Haruya Yamane   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy